Operating Expenses Summary of Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited's latest annual operating expenses in 2023 was 15.42 Billion CNY , down -9.0% from previous year.
Sino Biopharmaceutical Limited's latest quarterly operating expenses in 2024 Q1 was 4.71 Billion CNY , down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported a annual operating expenses of 16.94 Billion CNY in annual operating expenses 2022, down -1.38% from previous year.
Sino Biopharmaceutical Limited reported a annual operating expenses of 17.18 Billion CNY in annual operating expenses 2021, up 21.36% from previous year.
Sino Biopharmaceutical Limited reported a quarterly operating expenses of 4.71 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported a quarterly operating expenses of 4.4 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Operating Expenses of Sino Biopharmaceutical Limited (2023 - 1999)

Year	Operating Expenses	Operating Expenses Growth
2023	15.42 Billion CNY	-9.0%
2022	16.94 Billion CNY	-1.38%
2021	17.18 Billion CNY	21.36%
2020	14.16 Billion CNY	-0.39%
2019	14.21 Billion CNY	14.91%
2018	12.37 Billion CNY	46.14%
2017	8.46 Billion CNY	1.58%
2016	8.33 Billion CNY	17.71%
2015	7.08 Billion CNY	23.38%
2014	5.73 Billion CNY	24.26%
2013	4.61 Billion CNY	16.37%
2012	3.96 Billion CNY	38.98%
2011	2.85 Billion CNY	51.85%
2010	1.88 Billion CNY	18.48%
2009	1.58 Billion CNY	50.27%
2008	1.05 Billion CNY	75.78%
2007	600.86 Million CNY	67.37%
2006	359 Million CNY	-25.62%
2005	482.68 Million CNY	-25.56%
2004	648.39 Million CNY	22.89%
2003	527.62 Million CNY	21.17%
2002	435.45 Million CNY	28.66%
2001	338.44 Million CNY	43.94%
2000	235.13 Million CNY	39.37%
1999	168.71 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	4.71 Billion CNY	0.0%
2024 Q2	4.71 Billion CNY	0.0%
2023 Q2	4.4 Billion CNY	0.0%
2023 Q1	4.4 Billion CNY	27.08%
2023 Q3	- HKD	-100.0%
2023 FY	15.42 Billion CNY	-9.0%
2022 Q3	4.37 Billion CNY	2.74%
2022 Q2	4.26 Billion CNY	0.0%
2022 Q1	4.26 Billion CNY	240.04%
2022 FY	16.94 Billion CNY	-1.38%
2022 Q4	3.46 Billion CNY	-20.91%
2021 Q2	2.3 Billion CNY	-23.32%
2021 Q3	1.25 Billion CNY	-45.61%
2021 Q4	1.25 Billion CNY	0.0%
2021 FY	17.18 Billion CNY	21.36%
2021 Q1	3 Billion CNY	-17.84%
2020 Q4	3.65 Billion CNY	18.55%
2020 Q2	3.48 Billion CNY	-11.4%
2020 FY	14.16 Billion CNY	-0.39%
2020 Q1	3.93 Billion CNY	38.15%
2020 Q3	3.08 Billion CNY	-11.44%
2019 Q4	2.84 Billion CNY	-24.26%
2019 FY	14.21 Billion CNY	14.91%
2019 Q1	3.86 Billion CNY	6.28%
2019 Q3	3.75 Billion CNY	0.2%
2019 Q2	3.75 Billion CNY	-2.83%
2018 Q4	3.63 Billion CNY	23.59%
2018 FY	12.37 Billion CNY	46.14%
2018 Q1	2.83 Billion CNY	53.19%
2018 Q2	2.97 Billion CNY	4.92%
2018 Q3	2.93 Billion CNY	-1.07%
2017 Q4	1.84 Billion CNY	-9.31%
2017 Q3	2.03 Billion CNY	-5.09%
2017 Q2	2.14 Billion CNY	-11.74%
2017 FY	8.46 Billion CNY	1.58%
2017 Q1	2.43 Billion CNY	18.86%
2016 Q4	2.04 Billion CNY	2.77%
2016 Q1	2.26 Billion CNY	47.46%
2016 FY	8.33 Billion CNY	17.71%
2016 Q2	2.02 Billion CNY	-10.49%
2016 Q3	1.99 Billion CNY	-1.85%
2015 Q4	1.53 Billion CNY	-14.34%
2015 Q1	1.93 Billion CNY	38.24%
2015 Q3	1.79 Billion CNY	-0.84%
2015 FY	7.08 Billion CNY	23.38%
2015 Q2	1.8 Billion CNY	-6.63%
2014 Q1	1.5 Billion CNY	50.42%
2014 Q4	1.4 Billion CNY	4.42%
2014 Q3	1.34 Billion CNY	-9.85%
2014 Q2	1.48 Billion CNY	-0.97%
2014 FY	5.73 Billion CNY	24.26%
2013 Q4	999.97 Million CNY	-13.6%
2013 FY	4.61 Billion CNY	16.37%
2013 Q1	1.21 Billion CNY	18.95%
2013 Q2	1.24 Billion CNY	3.02%
2013 Q3	1.15 Billion CNY	-7.32%
2012 FY	3.96 Billion CNY	38.98%
2012 Q4	1.01 Billion CNY	-17.83%
2012 Q3	1.24 Billion CNY	62.07%
2012 Q1	944.09 Million CNY	41.69%
2012 Q2	765.23 Million CNY	-18.95%
2011 Q1	615.54 Million CNY	0.0%
2011 Q2	728.79 Million CNY	18.4%
2011 Q3	844.87 Million CNY	15.93%
2011 Q4	666.29 Million CNY	-21.14%
2011 FY	2.85 Billion CNY	51.85%
2010 Q1	455.63 Million CNY	0.0%
2010 Q2	535.75 Million CNY	17.58%
2010 FY	1.88 Billion CNY	18.48%
2009 FY	1.58 Billion CNY	50.27%
2008 FY	1.05 Billion CNY	75.78%
2007 FY	600.86 Million CNY	67.37%
2006 FY	359 Million CNY	-25.62%
2005 FY	482.68 Million CNY	-25.56%
2004 FY	648.39 Million CNY	22.89%
2003 FY	527.62 Million CNY	21.17%
2002 FY	435.45 Million CNY	28.66%
2001 FY	338.44 Million CNY	43.94%
2000 FY	235.13 Million CNY	39.37%
1999 FY	168.71 Million CNY	0.0%

Peer Operating Expenses Comparison of Sino Biopharmaceutical Limited

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-4645.06%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	-1986.4%

Global Stocks Search

Sino Biopharmaceutical Limited (1177.HK)

Operating Expenses Summary of Sino Biopharmaceutical Limited

Annual Operating Expenses Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Operating Expenses of Sino Biopharmaceutical Limited (2023 - 1999)

Peer Operating Expenses Comparison of Sino Biopharmaceutical Limited